The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

Completed · Not applicable

Conditions studied: Cancer, Bone Marrow Neoplasms, Anxiety, Depression, Quality of Life, Adherence, Medication, Coping Skills, Adolescent Behavior

In brief

Multisite Randomized Controlled Trial (RCT) testing the efficacy of the Promoting Resilience in Stress Management (PRISM) intervention among Adolescents and Young Adults receiving hematopoietic cell transplantation for hematology malignancy.

Key facts

Study ID

NCT03640325

Run by

Seattle Children's Hospital

People needed

143

Starts

2019-04-01

Expected to finish

2024-03-31

Last updated by the study team

2024-10-26

Who can join

Age: 12 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• AYA Child of caregiver agreed to participate
• One caregiver per patient-caregiver dyad
• Parent/guardian cognitively and physically able to participate
• Parent/guardian is able to speak/read English or Spanish

Where it is running

• University of Alabama, Birmingham — Birmingham, Alabama, United States
• Children's Hospital of Los Angeles — Los Angeles, California, United States
• Dana-Farber/Harvard Cancer Center — Boston, Massachusetts, United States
• St. Jude Children's Research Hospital — Memphis, Tennessee, United States
• Seattle Children's Hospital Cancer and Blood Disorders Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.